Sera Prognostics (SERA) Other financing activities (2020 - 2026)
Sera Prognostics (SERA) posted Other financing activities of $22000.0 for Q1 2026, down 94.91% on a QoQ basis from $432000.0 in Q4 2025, and down 53.19% year-over-year from $47000.0 in Q1 2025.
Sera Prognostics (SERA) Other financing activities (2020 - 2026) Analysis & Trends
Sera Prognostics' Other financing activities history runs 7 years deep, the most recent figure standing at $22000.0 for Q1 2026.
- Quarterly Other financing activities fell 53.19% year-over-year to $22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $482000.0 (up 149.79% YoY) and the FY2025 annual result came in at $507000.0, up 244.9% from the prior year.
- Other financing activities was $22000.0 for Q1 2026 at Sera Prognostics, down from $432000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.3 million in Q2 2024 and bottomed at -$2.5 million in Q4 2024.
- A 5-year average of $69187.5 and a median of $107000.0 in 2022 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 28950.0% in 2024, while the deepest fall reached 725.41% in 2024.
- Sera Prognostics' Other financing activities stood at $308000.0 in 2022, then plunged by 198.38% to -$303000.0 in 2023, then tumbled by 725.41% to -$2.5 million in 2024, then soared by 117.27% to $432000.0 in 2025, then slumped by 94.91% to $22000.0 in 2026.
- Business Quant data shows SERA's Other financing activities at $22000.0 in Q1 2026, $432000.0 in Q4 2025, and $28000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Sera Prognostics | 102.28 Mn | 102.28 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 432,000.00 |
| Dec 31, 2025 | 432,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | -2.50 Mn |
| Dec 31, 2024 | -2.50 Mn |
| Sep 30, 2024 | 228,000.00 |
| Sep 30, 2024 | 228,000.00 |
| Jun 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | -303,000.00 |
| Dec 31, 2023 | -303,000.00 |
| Sep 30, 2023 | 244,000.00 |
| Sep 30, 2023 | 244,000.00 |